|
|
|
Insider
Information: |
Garceau Roger |
Relationship: |
Director |
City: |
Bedminster |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
33,000 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$96,030 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
33,000 |
|
|
Total
Value |
$96,030 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
NPS Pharmaceuticals Inc |
NPSP |
SVP & CMO |
2015-02-21 |
0 |
2012-10-03 |
0 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
Director |
2020-01-10 |
33,000 |
2020-01-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TARA |
Protara Therapeutics, Inc |
Director |
|
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
33,000 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-21 |
4 |
D |
$46.00 |
$1,994,054 |
D/D |
(43,349) |
0 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-13 |
4 |
D |
$45.88 |
$250,505 |
D/D |
(5,460) |
43,349 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,531 |
48,809 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,832 |
39,842 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-12 |
4 |
D |
$45.85 |
$71,709 |
D/D |
(1,564) |
38,278 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP &CMO |
|
2015-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
41,448 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-07 |
4 |
D |
$45.85 |
$249,332 |
D/D |
(5,438) |
36,010 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,168 |
41,448 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2015-02-05 |
4 |
OE |
$45.88 |
$705,818 |
D/D |
15,384 |
52,448 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2014-02-13 |
4 |
D |
$38.30 |
$150,213 |
D/D |
(3,922) |
67,832 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,530 |
71,754 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2014-02-07 |
4 |
D |
$35.13 |
$188,683 |
D/D |
(5,371) |
61,224 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2014-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,167 |
66,595 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2013-08-30 |
4 |
AS |
$25.18 |
$2,769,877 |
D/D |
(110,000) |
64,146 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2013-08-30 |
4 |
OE |
$3.34 |
$521,691 |
D/D |
110,000 |
174,146 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CMO |
|
2013-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,500 |
73,849 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
EVP & CMO |
|
2013-02-19 |
4 |
D |
$8.01 |
$77,721 |
D/D |
(9,703) |
64,146 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2013-02-07 |
4 |
D |
$8.61 |
$48,095 |
D/D |
(5,586) |
46,349 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,165 |
51,935 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2012-10-03 |
4 |
AS |
$9.51 |
$1,337,119 |
D/D |
(140,625) |
0 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
SVP & CMO |
|
2012-10-03 |
4 |
OE |
$5.98 |
$840,938 |
D/D |
140,625 |
140,625 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|